Carcinogenicity of benzotrichloride administered to mice by gastric intubation.
Epidemiological studies suggest that benzotrichloride (BTC) is a human carcinogen. In the present study, BTC was tested to evaluate its ability to induce lung tumors as a result of systemic exposure. Administration of BTC by gastric intubation, 2.0-0.0315 microliters/mouse (4 doses), twice a week for 25 weeks, in female ICR mice, produced forestomach tumors (squamous cell carcinoma and papilloma), lung tumors (adenocarcinoma and adenoma) and tumors of the hematopoietic system (thymic lymphosarcoma and lymphatic leukemia) with dose-related response by 18 months. The present and previous studies indicate that the target organs of BTC carcinogenesis in mice are the local tissue which is primarily exposed, and the lung and hematopoietic tissue when BTC is administered systematically.
Fukuda
K
K
Matsushita
H
H
Takemoto
K
K
Toya
T
T
D000284:Administration, Oral; D000818:Animals; D015197:Carcinogenicity Tests; D005260:Female; D008175:Lung Neoplasms / Q000139:chemically induced; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced; D051379:Mice; D008813:Mice, Inbred ICR; D009369:Neoplasms / Q000139:chemically induced*; D013047:Specific Pathogen-Free Organisms; D013274:Stomach Neoplasms / Q000139:chemically induced; D013953:Thymus Neoplasms / Q000139:chemically induced; D014050:Toluene / Q000031:analogs & derivatives* / Q000633:toxicity
D014050:Toluene; C018847:benzotrichloride